ChimeriVax Tetravalent Dengue Vaccine
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ChimeriVax Tetravalent Dengue Vaccine, covering 2019-07-24 to 2019-07-29. Get the full timeline:
Most recent: Clinical Trial Update: Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 Years [Phase 2]